STUDY ON THE INHIBITORY EFFECT OF DRYNARIA FORTUNEI EXTRACT ON HUMAN MYELOMA SP20 CELLS

Authors

  • Baofeng Li
  • Tingting Duan
  • Lei Fan

Keywords:

Drynaria fortunei, Flavonoid compounds, Mouse SP2/0 tumour, Inhibitory.

Abstract

The objective of the study was to investigate the inhibitory effect of Drynaria fortunei extract on human myeloma SP2 cells. Three different total extracts of Drynaria fortunei were obtained by reflux extraction method using different organic solvents including ethanol, methanol and petroleum ether. Their anticancer activities on SP20 cells were tested, and the maximum inhibition rate was obtained. The inhibitory effects on tumour cells at 12 h, 24 h, 36 h and 48 h were tested, and the inhibition curves at different time periods were plotted. The results showed that the methanol and ethanol extracts have similar inhibition rates at 24 h, which are around 55%. On the other hand, the maximum inhibition rate of petroleum ether extract is only 36% within 24h. Moreover, within the time periods of 36 h and 48 h, its inhibition rates are all below 10%.

Author Biography

Baofeng Li

Orthopaedics Department, The Affiliated hospital of Shandong University of Traditional Chinese Medicine, 250014, Ji Nan, China

Downloads

Published

2013-07-04

How to Cite

Li, B., Duan, T., & Fan, L. (2013). STUDY ON THE INHIBITORY EFFECT OF DRYNARIA FORTUNEI EXTRACT ON HUMAN MYELOMA SP20 CELLS. African Journal of Traditional, Complementary and Alternative Medicines, 10(5), 375–379. Retrieved from https://athmsi.org/journals/index.php/ajtcam/article/view/1963

Issue

Vol. 10 No. 5 (2013)

Section

Research Papers

License

Copyright: Creative Commons Attribution CC.

This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.